Agape ATP Corporation (NASDAQ:ATPC) Short Interest Update

Agape ATP Corporation (NASDAQ:ATPC) saw a large growth in short interest during the month of May. As of May 29th, there was short interest totaling 314,161 shares, a growth of 5,924.2% from the May 14th total of 5,215 shares. Based on an average daily trading volume, of 12,517,087 shares, the days-to-cover ratio is presently 0.0 days. Approximately 32.0% of the shares of the company are short sold.

Wall Street Analysts Forecast Growth

ATPC has been the subject of a number of recent research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Agape ATP in a research report on Friday, May 22nd. Wall Street Zen raised shares of Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Agape ATP has an average rating of “Sell”.

Institutional Investors Weigh In On Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC boosted its stake in Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 65,130 shares of the company’s stock after acquiring an additional 31,849 shares during the quarter. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent filing with the SEC. 0.01% of the stock is owned by institutional investors.

Agape ATP Price Performance

Shares of NASDAQ ATPC opened at $3.12 on Wednesday. The stock has a market capitalization of $3.12 million, a price-to-earnings ratio of -2.35 and a beta of 0.08. Agape ATP has a 12 month low of $1.72 and a 12 month high of $85.50. The firm’s 50 day simple moving average is $2.82 and its 200-day simple moving average is $9.39.

Agape ATP (NASDAQ:ATPC) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.33) EPS for the quarter. The firm had revenue of $0.27 million for the quarter. Agape ATP had a negative return on equity of 8.43% and a negative net margin of 125.89%.

Agape ATP Company Profile

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.